Live birth outcomes from IVF treatments in younger patients with low AMH

Autor:	Yoichi Aoki, Keiko Mekaru, Kozue Akamine, Maho Miyagi, Rie Nakamura, Chiaki Heshiki, Sugiko Oishi
Rok vydání:	2021
Předmět:	Anti-Mullerian Hormone endocrine system medicine.medical_specialty Pregnancy Rate endocrine system diseases medicine.medical_treatment Oocyte Retrieval Fertilization in Vitro live birth ovarian reserve Ovulation Induction Pregnancy medicine Humans Ovarian reserve Retrospective Studies In vitro fertilisation biology urogenital system Obstetrics business.industry Blastocyst Transfer Anti-Müllerian hormone medicine.disease female genital diseases and pregnancy complications Pregnancy rate anti-Müllerian hormone biology.protein Original Article Female Live birth business in vitro fertilization hormones hormone substitutes and hormone antagonists Hormone
Zdroj:	JBRA Assisted Reproduction
ISSN:	1518-0557
Popis:	Objective: Anti-Müllerian hormone (AMH) is used to predict in vitro fertilization outcomes. However, predicting live birth is difficult in younger patients with low AMH. Thus, this study aimed to determine the live birth rates from younger patients with low anti-Müllerian hormone levels. Methods: A total of 296 infertile patients with AMH measured (younger group, aged 25-38 years; older group, aged 39-42 years) were included in this study. In vitro fertilization outcomes between patients with AMH levels of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ea1d31a006b858343b18ef7d2fcc89 https://doi.org/10.5935/1518-0557.20210006 Zobrazit plný text záznamu